Sclerosing Epithelioid Fibrosarcoma

[1]  B. Dickson,et al.  VIM::KMT2A‐rearranged sarcomas: A report of two new cases confirming an entity with distinct histologic features , 2023, Genes, chromosomes & cancer.

[2]  A. Folpe.  ‘I Can’t Keep Up!’: an update on advances in soft tissue pathology occurring after the publication of the 2020 World Health Organization classification of soft tissue and bone tumours , 2021, Histopathology.

[3]  Yongqiang Shi,et al.  Primary Sclerosing Epithelioid Fibrosarcoma of the Kidney: A Case Report and Review of the Literature , 2021, International journal of surgical pathology.

[4]  A. D. Dei Tos,et al.  Primary sclerosing epithelioid fibrosarcoma of the spine: a single‐institution experience , 2021, Histopathology.

[5]  G. Schwartz,et al.  Clinical Benefit From Immune Checkpoint Blockade in Sclerosing Epithelioid Fibrosarcoma: A Translocation-Associated Sarcoma , 2021 .

[6]  A. Marx,et al.  Molecular pathology of thymomas: implications for diagnosis and therapy , 2021, Virchows Archiv.

[7]  J. Hornick,et al.  MUC4 is expressed in alveolar rhabdomyosarcoma , 2020, Histopathology.

[8]  J. Meis,et al.  Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features. , 2020, The American journal of surgical pathology.

[9]  Adham Ammar,et al.  Hybrid sclerosing epithelioid fibrosarcoma/low grade fibromyxoid sarcoma arising in the small intestine with distinct HEY1-NCOA2 gene fusion. , 2020, Pathology.

[10]  L. Pantanowitz,et al.  Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases. , 2020, Journal of the American Society of Cytopathology.

[11]  E. Sokol,et al.  Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions , 2020, Modern Pathology.

[12]  S. Dry,et al.  Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature , 2020, Genes, chromosomes & cancer.

[13]  R. Maruyama,et al.  A case of cellular variants of Sclerosing epithelioid fibrosarcoma resembling Plasmacytoma/Myeloma: Diagnostic difficulty in the fine needle aspiration , 2020, International journal of surgery case reports.

[14]  C. Antonescu,et al.  A morphologic and molecular reappraisal of genetically confirmed myoepithelial tumors of soft tissue, bone and viscera. , 2020, Genes, chromosomes & cancer.

[15]  R. Stoehr,et al.  Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma , 2020, The American journal of surgical pathology.

[16]  Rajiv M. Patel,et al.  Ossifying Fibromyxoid Tumor: A Review With Emphasis on Recent Molecular Advances and Differential Diagnosis. , 2019, Archives of pathology & laboratory medicine.

[17]  T. Itoh,et al.  A novel EWSR1‐VGLL1 gene fusion in a soft tissue malignant myoepithelial tumor , 2019, Genes, chromosomes & cancer.

[18]  Narasimhan P. Agaram,et al.  Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma , 2019, The American journal of surgical pathology.

[19]  T. Shibata,et al.  KMT2A (MLL) fusions in aggressive sarcomas in young adults , 2019, Histopathology.

[20]  Robin L. Jones,et al.  Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma , 2018, Medical Oncology.

[21]  B. Rubin,et al.  Ewing Sarcoma and the History of Similar and Possibly Related Small Round Cell Tumors: From Whence Have We Come and Where are We Going? , 2018, Advances in anatomic pathology.

[22]  O. Delattre,et al.  Transcriptomic definition of molecular subgroups of small round cell sarcomas , 2018, The Journal of pathology.

[23]  C. Antonescu,et al.  In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets , 2017, Clinical Cancer Research.

[24]  R. Sciot,et al.  A novel EWS‐CREB3L3 gene fusion in a mesenteric sclerosing epithelioid fibrosarcoma , 2017, Genes, chromosomes & cancer.

[25]  E. Clappier,et al.  The MLL recombinome of acute leukemias in 2017 , 2017, Leukemia.

[26]  A. D. Dei Tos,et al.  HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma , 2017, Genes, chromosomes & cancer.

[27]  F. Mertens,et al.  Non‐fibrosing sclerosing epithelioid fibrosarcoma: an unusual variant , 2016, Histopathology.

[28]  J. Bridge,et al.  Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature , 2015, Diagnostic Pathology.

[29]  Narasimhan P. Agaram,et al.  A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low‐grade fibromyxoid sarcoma: A pathologic and molecular study of 18 cases , 2015, Genes, chromosomes & cancer.

[30]  John B Wojcik,et al.  Primary Sclerosing Epithelioid Fibrosarcoma of Bone: Analysis of a Series , 2014, The American journal of surgical pathology.

[31]  Siraj M. Ali,et al.  Sclerosing epithelioid fibrosarcoma presenting as intraabdominal sarcomatosis with a novel EWSR1-CREB3L1 gene fusion. , 2014, Human pathology.

[32]  C. Fisher,et al.  Recurrent EWSR1-CREB3L1 Gene Fusions in Sclerosing Epithelioid Fibrosarcoma , 2014, The American journal of surgical pathology.

[33]  J. Goldblum,et al.  PHF1 Rearrangements in Ossifying Fibromyxoid Tumors of Soft Parts: A Fluorescence In Situ Hybridization Study of 41 Cases With Emphasis on the Malignant Variant , 2013, The American journal of surgical pathology.

[34]  J. Chan,et al.  EWSR1-CREB3L1 Gene Fusion: A Novel Alternative Molecular Aberration of Low-grade Fibromyxoid Sarcoma , 2013, The American journal of surgical pathology.

[35]  N. Jhala,et al.  Sclerosing epithelioid fibrosarcoma of the pancreas. , 2013, Annals of diagnostic pathology.

[36]  R. Lothe,et al.  Whole-Transcriptome Sequencing Identifies Novel IRF2BP2-CDX1 Fusion Gene Brought about by Translocation t(1;5)(q42;q32) in Mesenchymal Chondrosarcoma , 2012, PloS one.

[37]  P. D. Dal Cin,et al.  MUC4 Is a Sensitive and Extremely Useful Marker for Sclerosing Epithelioid Fibrosarcoma: Association With FUS Gene Rearrangement , 2012, The American journal of surgical pathology.

[38]  O. Larsson,et al.  Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors. , 2012, The American journal of pathology.

[39]  J. Aaron.  Periosteal Sharpey’s fibers: a novel bone matrix regulatory system? , 2012, Front. Endocrin..

[40]  J. Goldblum,et al.  FUS rearrangements are rare in ‘pure’ sclerosing epithelioid fibrosarcoma , 2012, Modern Pathology.

[41]  B. Tops,et al.  EWSR1-ATF1 chimeric transcript in a myoepithelial tumor of soft tissue: a case report. , 2012, Human pathology.

[42]  D. Gisselsson,et al.  Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma , 2012, Oncogene.

[43]  N. Socci,et al.  Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression data , 2012, Genes, chromosomes & cancer.

[44]  S. Raimondi,et al.  Ossifying Fibromyxoid Tumor of Soft Parts: A Clinicopathologic, Proteomic, and Genomic Study , 2011, The American journal of surgical pathology.

[45]  M. Deshmukh,et al.  Low-grade fibromyxoid sarcoma: a clinicopathologic study of 18 cases, including histopathologic relationship with sclerosing epithelioid fibrosarcoma in a subset of cases. , 2011, Annals of diagnostic pathology.

[46]  H. Evans.  Low-Grade Fibromyxoid Sarcoma: A Clinicopathologic Study of 33 Cases With Long-Term Follow-Up , 2011, The American journal of surgical pathology.

[47]  P. Wakely,et al.  Sclerosing Epithelioid Fibrosarcoma of the Oral Cavity , 2011, Head and neck pathology.

[48]  P. Cin,et al.  Autopsy , 2011, Laboratory Investigation.

[49]  A. Folpe,et al.  Sclerosing Epithelioid Fibrosarcoma–A Report of Two Cases with Cytogenetic Analysis of FUS Gene Rearrangement by FISH Technique , 2011, Pathology & Oncology Research.

[50]  C. Antonescu,et al.  EWSR1‐POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene , 2010, Genes, chromosomes & cancer.

[51]  Y. Otsuki,et al.  Cytology of sclerosing epithelioid fibrosarcoma in pleural effusion , 2010, Diagnostic cytopathology.

[52]  S. Bielack,et al.  Sclerosing Epithelioid Fibrosarcoma of the Bone: A Case Report of High Resistance to Chemotherapy and a Survey of the Literature , 2010, Sarcoma.

[53]  B. Eyden,et al.  A Primary Sclerosing Epithelioid Fibrosarcoma of the Pubic Bone, with Evidence of Divergent Epithelial Differentiation , 2010, Ultrastructural pathology.

[54]  J. Sosa,et al.  Sclerosing epithelioid fibrosarcoma of the cecum: a radiation-associated tumor in a previously unreported site. , 2009, Archives of pathology & laboratory medicine.

[55]  Philip J. Smith,et al.  Sclerosing epithelioid fibrosarcoma as a rare cause of ascites in a young man: a case report , 2008, Journal of medical case reports.

[56]  J. Fanburg–Smith,et al.  Oral and Maxillofacial Sclerosing Epithelioid Fibroscarcoma: Report of Five Cases , 2007, Head and neck pathology.

[57]  Lynette M. Smith,et al.  Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125) , 2006, Modern Pathology.

[58]  C. Antonescu,et al.  Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene , 2005, Laboratory Investigation.

[59]  A. Ogose,et al.  Sclerosing epithelioid fibrosarcoma with der(10)t(10;17)(p11;q11). , 2004, Cancer genetics and cytogenetics.

[60]  F. Mertens,et al.  Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma. , 2003, Human molecular genetics.

[61]  D. Gisselsson,et al.  A novel fusion gene, SS18L1/SSX1, in synovial sarcoma , 2003, Genes, chromosomes & cancer.

[62]  A. Folpe,et al.  Ossifying Fibromyxoid Tumor of Soft Parts: A Clinicopathologic Study of 70 Cases With Emphasis on Atypical and Malignant Variants , 2003, The American journal of surgical pathology.

[63]  A. Sandberg,et al.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma. , 2002, Cancer genetics and cytogenetics.

[64]  H. Friess,et al.  Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[65]  C. Antonescu,et al.  Sclerosing Epithelioid Fibrosarcoma: A Study of 16 Cases and Confirmation of a Clinicopathologically Distinct Tumor , 2001, The American journal of surgical pathology.

[66]  M. Emberton,et al.  A rare tumour in the pelvis presenting with lower urinary symptoms: 'sclerosing epithelioid fibrosarcoma'. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[67]  J. Woodruff,et al.  Role of electron microscopy in the evaluation of soft tissue neoplasms, with emphasis on spindle cell and pleomorphic tumors. , 1998, Human pathology.

[68]  D. Hamblen,et al.  Sclerosing epithelioid fibrosarcoma , 1996, Histopathology.

[69]  L. Kindblom,et al.  Sclerosing Epithelioid Fibrosarcoma: A Variant of Fibrosarcoma Simulating Carcinoma , 1995, The American journal of surgical pathology.

[70]  S. Weiss,et al.  Ossifying Fibromyxoid Tumor of Soft Parts: A Clinicopathological Analysis of 59 Cases , 1989, The American journal of surgical pathology.

[71]  H. Evans,et al.  Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. , 1987, American journal of clinical pathology.

[72]  L. Kindblom,et al.  The ultrastructure of myxofibrosarcoma , 1979, Virchows Archiv A.

[73]  R. Ramsamooj,et al.  Sclerosing epithelioid fibrosarcoma: short T2 on MR imaging. , 1997, Skeletal radiology.

[74]  A. Odén,et al.  Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis. , 1983, Acta pathologica, microbiologica, et immunologica Scandinavica. Supplement.